Live Breaking News & Updates on Navidea Biopharmaceuticals Inc|Page 4

Stay updated with breaking news from Navidea biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Navidea Manocept , Theodore Gerbick , Exchange Commission , Navidea Biopharmaceuticals Inc , Exchange Act The Deregistration , Securities Exchange , Navidea Biopharmaceuticals , Securities Exchange Act , Exchange Act , Securities Act , Annual Report ,

Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.06 on Wednesday. Navidea Biopharmaceuticals has a one year low of $0.02 and a one year high of […] ....

Navidea Biopharmaceuticals Company Profile , Navidea Biopharmaceuticals Inc , Allred Capital Management , Renaissance Technologies , Therapeutic Development Programs , Navidea Biopharmaceuticals , Free Report , Get Free Report , Capital Management , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 8.9 % Shares of NYSE NAVB opened at $0.06 on Wednesday. The stock has a fifty day moving average price […] ....

Renaissance Technologies , Navidea Biopharmaceuticals Inc , Therapeutic Development Programs , Allred Capital Management , Navidea Biopharmaceuticals , Get Free Report , Capital Management , State Street Corp , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Receives New Coverage from Analysts at StockNews.com

StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.05 on Monday. The firm’s fifty day moving average is $0.06 and its 200-day moving average is $0.07. Navidea Biopharmaceuticals […] ....

Navidea Biopharmaceuticals Inc , Navidea Biopharmaceuticals Company Profile , Renaissance Technologies , Therapeutic Development Programs , Allred Capital Management , Navidea Biopharmaceuticals , Free Report , Get Free Report , Street Corp , Capital Management , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,

Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.com

StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of Navidea Biopharmaceuticals stock opened at $0.05 on Friday. The business has a fifty day simple moving average of $0.06 […] ....

Navidea Biopharmaceuticals Company Profile , Therapeutic Development Programs , Allred Capital Management , Navidea Biopharmaceuticals Inc , Renaissance Technologies , Navidea Biopharmaceuticals , Free Report , Get Free Report , Capital Management , State Street Corp , Street Corp , Diagnostic Substances , Therapeutic Development , Navidea Biopharmaceuticals Daily , Nyse Navb , Initiated Coverage , Stocknews Com ,